EPISODE · Feb 14, 2026 · 53 MIN
First Human Cellular Reprogramming Trial Cleared by FDA, GLP-1 Muscle Mass Loss, Older Americans Quitting Weight Loss Drugs 2-10-26
from News for the Ages by Rethinking Aging Club · host Co-Hosts: Linda Sherman and Ray Gordon Presenters: Benjamin Surmi, Ellen Khalifa and Elizabeth Magallon Fleury
Our News for the Ages by Rethinking Aging Club, Feb 10, 2026 episode discussed the FDA's approval of a study on reprogramming genes to reverse eye damage in glaucoma patients using viruses carrying three reprogramming genes. The study aims to regenerate blood flow to the optic nerve. Concerns were raised about muscle loss and functional strength reduction in GLP-1 drug users, with 47% of users discontinuing within a year due to side effects and cost. The Biden administration's efforts to cap out-of-pocket costs for Medicare beneficiaries were noted, but Medicare's current regulations prohibit coverage for weight loss drugs.Presented by Benjamin Surmi, Senior Living Expert and Social GerontologistMIT Technology Review 1-27-26 First Human Test of Rejuvenation Method Will Begin Shortly by Antonio Regaladohttps://www.technologyreview.com/2026/01/27/1131796/the-first-human-test-of-a-rejuvenation-method-will-begin-shortly/Lifespan Research Institute 2-6-26 First Human Cellular Reprogramming Trial Cleared by the FDA by Arkadi Mazinhttps://lifespan.io/news/first-human-cellular-reprogramming-trial-cleared-by-the-fda/We referred to “pluripotency” and defined it.We mentioned Shinya Yamanaka and the “Yamanaka Factors.”Presented by Ray Gordon, Architect, Urban Planner, Futurist and Former Pratt Institute Grad School Professor Vox 12-3-25 GLP-1 and Muscle Mass Loss by Dylan Scotthttps://www.vox.com/the-highlight/469742/ozempic-wegovy-zepbound-mounjaro-weight-loss-side-effects-muscleApple access: https://apple.news/AMGI3ozp8S923OYsSAf1p_APresented by Ellen Khalifa, Habits Coach for Healthspan and Wellspan NY Times 12-21-26 Older Americans Quit Weight-Loss Drugs in Droves by Paula Spanhttps://www.nytimes.com/2025/12/21/health/older-people-glp1-weight.htmlLinda referred to Benjamin’s excellent 2-4-26 article with Joe & Bellahttps://joeandbella.com/blogs/news/rethinking-care-what-makes-life-worth-living-as-we-age-part-iDiscussion hosted with commentary by: Linda Sherman and Ray Gordon.BoomerTechTalk.com episode page 2-10-26 LinkedIn Show PostNews for the Ages podcasts live on Tuesdays. How to join live.Please follow both of our podcasts including Rethinking Aging Club Podcast.Nickie’s Tune written and performed by Richard Sherman
Embed this episode
What this episode covers
Our News for the Ages by Rethinking Aging Club, Feb 10, 2026 episode discussed the FDA's approval of a study on reprogramming genes to reverse eye damage in glaucoma patients using viruses carrying three reprogramming genes. The study aims to regenerate blood flow to the optic nerve. Concerns were raised about muscle loss and functional strength reduction in GLP-1 drug users, with 47% of users discontinuing within a year due to side effects and cost. The Biden administration's efforts t...
Ready to play
First Human Cellular Reprogramming Trial Cleared by FDA, GLP-1 Muscle Mass Loss, Older Americans Quitting Weight Loss Drugs 2-10-26
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.